New Drug Decisions

Decisions on medicines are made by the Formulary Committee (FC) which is a subcommittee of the Area Drugs and Therapeutics Committee (ADTC).

The following webtables detail all decisions made on medicines since 2002. The content is broken down by therapeutic area, mirroring BNF chapters.

The SMC website should be accessed for full details of SMC decisions.

Gatro-intestinal System

Cardiovascular System

Respiratory System

Central Nervous System


Endocrine System

Obstetrics, Gynaecology and Urinary-tract Disorders

Malignant Disease and Immunosuppression

Nutrition and Blood

Musculoskeletal and Joint Diseases


Ear, Nose and Oropharynx



Recommendations on medical devices

Medicines are classified as:

Formulary Drugs

(a) Included in the Lothian Joint Formulary; first or second choice or in the prescribing notes

(b) Additional List: are approved for use in specialist units or when formulary drugs are ineffective, not tolerated or are contraindicated.

Non Formulary Drugs

(a) Not included: recommended by the SMC but not included in Lothian as suitable alternatives exist or an application has not been made to the Formulary Committee.  (Prescribing of these medicines can be approved through the non-approved medicines route.)

(b) Not recommended: not recommended by the SMC (as not cost effective), therefore, nor by the ADTC/Formulary Committee for use in Lothian.  (Prescribing of these medicines may be approved through the IPTR route, where appropriate.)

Unlicensed medicines are classified by a traffic light system as set out in the ADTC NHS Lothian 'Policy and procedures for the Use of unlicensed medicines' - see full document via this link.

RED: Specialist Use only

AMBER: General Use with restrictions

GREEN: Unrestricted General Use

BLACK: Not approved for use

As per the new standard template for recording decisions developed by the ADTC Collaborative, Formulary Committee will classify medicines using the standard wording as below:

Routinely available in line with national guidance;

Routinely available in line with local or regional guidance;

Routinely available from a specialist centre in another health board;

Not routinely available as not recommended for use in NHSScotland;

Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines;

Not routinely available as local implementation plans are being developed or the FC is waiting for further advice from local clinical experts - decision expected by [date]